- Home
- CLX vs UTHR Comparison
CLX vs UTHR Comparison
Compare CLX & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLX
- UTHR
- Stock Information
- Founded
- CLX 1913
- UTHR 1996
- Country
- CLX United States
- UTHR United States
- Employees
- CLX N/A
- UTHR N/A
- Industry
- CLX Specialty Chemicals
- UTHR Biotechnology: Pharmaceutical Preparations
- Sector
- CLX Consumer Discretionary
- UTHR Health Care
- Exchange
- CLX Nasdaq
- UTHR Nasdaq
- Market Cap
- CLX 15.1B
- UTHR 13.8B
- IPO Year
- CLX N/A
- UTHR 1999
- Fundamental
- Price
- CLX $122.19
- UTHR $313.13
- Analyst Decision
- CLX Hold
- UTHR Buy
- Analyst Count
- CLX 12
- UTHR 13
- Target Price
- CLX $143.83
- UTHR $382.00
- AVG Volume (30 Days)
- CLX 1.8M
- UTHR 691.8K
- Earning Date
- CLX 07-31-2025
- UTHR 07-30-2025
- Dividend Yield
- CLX 4.06%
- UTHR N/A
- EPS Growth
- CLX 189.78
- UTHR 17.94
- EPS
- CLX 6.52
- UTHR 25.63
- Revenue
- CLX $7,104,000,000.00
- UTHR $3,077,800,000.00
- Revenue This Year
- CLX N/A
- UTHR $14.37
- Revenue Next Year
- CLX $3.68
- UTHR $6.59
- P/E Ratio
- CLX $18.74
- UTHR $12.22
- Revenue Growth
- CLX 0.15
- UTHR 17.62
- 52 Week Low
- CLX $117.35
- UTHR $266.98
- 52 Week High
- CLX $171.37
- UTHR $417.82
- Technical
- Relative Strength Index (RSI)
- CLX 40.67
- UTHR 61.16
- Support Level
- CLX $120.66
- UTHR $292.34
- Resistance Level
- CLX $123.28
- UTHR $306.00
- Average True Range (ATR)
- CLX 2.41
- UTHR 9.55
- MACD
- CLX -0.48
- UTHR 1.92
- Stochastic Oscillator
- CLX 20.66
- UTHR 97.36
About CLX Clorox Company (The)
Since its start more than 100 years ago, Clorox has expanded to operate in a variety of consumer products categories, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. More than 80% of Clorox's sales come from its home turf.
About UTHR United Therapeutics Corporation
United Therapeutics Corp specializes in drug development for pulmonary arterial hypertension (PAH), a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. The company markets and sells the following commercial therapies in the United States to treat PAH: Tyvaso DPI (treprostinil) Inhalation Powder, Remodulin Injection, Orenitram (treprostinil) Extended-Release Tablets, Adcirca (tadalafil) Tablets, and Unituxin. In addition, it is developing a pipeline of projects that includes new indications and delivery devices for existing products and new products to treat PAH and other conditions.